Cargando…
Nicotinamide adenine dinucleotide suppresses epileptogenesis at an early stage
The pathophysiologic mechanisms of epileptogenesis are poorly understood, and no effective therapy exists for suppressing epileptogenesis. Numerous reports have shown that nicotinamide adenine dinucleotide (NAD(+)) has neuroprotective effects, suggesting its potential use for treating epileptogenesi...
Autores principales: | Liu, Juan, Yang, Beimeng, Zhou, Pei, Kong, Yingying, Hu, Weiwei, Zhu, Geng, Ying, Weihai, Li, Weidong, Wang, Yun, Li, Shengtian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544671/ https://www.ncbi.nlm.nih.gov/pubmed/28779137 http://dx.doi.org/10.1038/s41598-017-07343-0 |
Ejemplares similares
-
Nicotinamide Adenine Dinucleotide Precursor Suppresses Hepatocellular Cancer Progression in Mice
por: Pang, Nengzhi, et al.
Publicado: (2023) -
Nicotinamide adenine dinucleotide as a photocatalyst
por: Kim, Jinhyun, et al.
Publicado: (2019) -
Metabolism and biochemical properties of nicotinamide adenine dinucleotide (NAD) analogs, nicotinamide guanine dinucleotide (NGD) and nicotinamide hypoxanthine dinucleotide (NHD)
por: Yaku, Keisuke, et al.
Publicado: (2019) -
Nicotinamide adenine dinucleotide is transported into mammalian mitochondria
por: Davila, Antonio, et al.
Publicado: (2018) -
Pharmacology and Potential Implications of Nicotinamide Adenine Dinucleotide Precursors
por: She, Jing, et al.
Publicado: (2021)